載入...
Immunotherapeutic approaches for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a cancer with a high mortality rate due to the fact that the diagnosis usually occurs at anadvanced stage. Even in case of curative surgical treatment, recurrence is common. Sorafenib and regorafenib are the only therapeutic agents that have been demonstrated to be...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5464921/ https://ncbi.nlm.nih.gov/pubmed/28420805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15406 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|